- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01986179
Comparing Remote Interpreter Modalities in the Pediatric Emergency Department
Impact of Remote Interpreter Modality on Comprehension, Communication Quality, and Consistency of Interpreter Use in the Pediatric Emergency Department
Professional interpretation improves quality of care for patients with limited English proficiency (LEP). However, many health care settings lack access to professional interpreters, and even in locations with good access, logistical factors and perceived barriers have limited their widespread use. Remote methods of professional interpretation, including telephone and video, hold great promise for expanding access, but only limited data exist on the relative impacts of these modalities on patient care and provider uptake. Comparing how these modalities impact multiple aspects of health care quality, including family comprehension, provider communication, and consistency of provider interpreter use will inform dissemination of strategies for delivery of safe, efficient, and equitable care to LEP families.
Aim 1: To determine whether randomly assigned remote interpreter modality (telephone versus video) impacts parent-reported quality of communication and interpretation, diagnosis comprehension, and length of stay (LOS) among LEP Spanish-speaking families seen in a pediatric Emergency Department (ED).
Hypothesis 1: Parent-reported quality of communication and interpretation and parent diagnosis comprehension will be higher among families assigned to video interpretation compared to telephone interpretation.
Hypothesis 2: LOS will not differ between families assigned to video and telephone interpretation.
Aim 2: To determine whether assigned interpreter modality is associated with provider decision to communicate without professional interpretation.
Hypothesis 3: Parent-reported provider communication without professional interpretation (e.g. using the patient or a family member to interpret for some part of the visit) will be lower for families assigned to video interpretation compared to telephone interpretation.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Washington
-
Seattle, Washington, United States, 98105
- Seattle Children's Hospital Emergency Department
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Preferred language for medical care of Spanish
- At least one primary caregiver requires interpretation
- Presenting to Seattle Children's ED during recruiting hours
Exclusion Criteria:
- Triage level 1 (life-threatening illness)
- No parent or legal guardian present
- Reason for visit is concern for abuse
- reason for visit is primary behavioral or psychiatric complaint
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Telephone Interpretation
These families will be assigned to use telephone interpretation throughout the ED visit.
|
Professional interpretation provided over the phone by a national network of certified medical interpreters
|
|
Experimental: Video Interpretation
These families will be assigned to use video interpretation throughout the ED visit.
|
Professional interpretation provided over video by a national network of certified medical interpreters
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Communication Quality
Time Frame: Once, 1-7 days after the ED visit
|
We will use the Consumer Assessment of Healthcare Providers and Systems (CAHPS) Child Visit Survey 2.0 communication composite, which includes 5 items.
|
Once, 1-7 days after the ED visit
|
|
Interpretation Quality
Time Frame: Once, 1-7 days after ED visit
|
Interpretation quality will be measured with the Interpreter Satisfaction Survey (7 items).
|
Once, 1-7 days after ED visit
|
|
Diagnosis Comprehension
Time Frame: Once, 1-7 days after ED visit
|
Parents will be asked to name their child's diagnosis.
Clinician-recorded diagnosis will be obtained from chart review for comparison.
Responses will be classified as correct, incorrect, or vague/incomplete, using a method we have employed previously.
|
Once, 1-7 days after ED visit
|
|
Consistency of Interpreter Use
Time Frame: Once, 1-7 days after ED visit
|
Parents will be asked to report on the frequency with which providers used each of a list of potential communication methods (e.g.
telephone interpreter, family or friend, spoke in English without an interpreter present).
Response options are never, sometimes, frequently, or always.
|
Once, 1-7 days after ED visit
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Length of ED stay
Time Frame: Once, after ED visit
|
Time from arrival in Emergency Department to discharge home or admission to the hospital.
|
Once, after ED visit
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: K. Casey Lion, MD, MPH, Seattle Children's Hospital
Publications and helpful links
General Publications
- Lion KC, Gritton J, Scannell J, Brown JC, Ebel BE, Klein EJ, Mangione-Smith R. Patterns and Predictors of Professional Interpreter Use in the Pediatric Emergency Department. Pediatrics. 2021 Feb;147(2). pii: e20193312. doi: 10.1542/peds.2019-3312.
- Lion KC, Brown JC, Ebel BE, Klein EJ, Strelitz B, Gutman CK, Hencz P, Fernandez J, Mangione-Smith R. Effect of Telephone vs Video Interpretation on Parent Comprehension, Communication, and Utilization in the Pediatric Emergency Department: A Randomized Clinical Trial. JAMA Pediatr. 2015 Dec;169(12):1117-25. doi: 10.1001/jamapediatrics.2015.2630.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 14647
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.